A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

NCT02072993 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

116

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopping criteria has been reached

Conditions

Healthy Subjects

Interventions

DRUG: AZD1979
DRUG: Placebo to match

Sponsor

AstraZeneca